Meena Kanduri
Department of Clinical Chemistry and Transfusion Medicine,
Institute of Biomedicine,
Department of Clinical Chemistry and Transfusion Medicine, Institute of Biomedicine
Gothenburg University
Meena Kanduri has not added Biography.
If you are Meena Kanduri and would like to personalize this page please email our Author Liaison for assistance.
A differentially methylated imprinting control region within the Kcnq1 locus harbors a methylation-sensitive chromatin insulator.
The Journal of biological chemistry May, 2002 | Pubmed ID: 11877438
Multiple nucleosome positioning sites regulate the CTCF-mediated insulator function of the H19 imprinting control region.
Molecular and cellular biology May, 2002 | Pubmed ID: 11971967
The kinetics of deregulation of expression by de novo methylation of the h19 imprinting control region in cancer cells.
Cancer research Aug, 2002 | Pubmed ID: 12183402
Bidirectional silencing and DNA methylation-sensitive methylation-spreading properties of the Kcnq1 imprinting control region map to the same regions.
The Journal of biological chemistry Mar, 2003 | Pubmed ID: 12511562
The binding sites for the chromatin insulator protein CTCF map to DNA methylation-free domains genome-wide.
Genome research Aug, 2004 | Pubmed ID: 15256511
An antisense RNA regulates the bidirectional silencing property of the Kcnq1 imprinting control region.
Molecular and cellular biology Sep, 2004 | Pubmed ID: 15340049
The DNA binding activities of Smad2 and Smad3 are regulated by coactivator-mediated acetylation.
The Journal of biological chemistry Dec, 2006 | Pubmed ID: 17074756
TP53 mutations predict for poor survival in de novo diffuse large B-cell lymphoma of germinal center subtype.
Leukemia research Jan, 2009 | Pubmed ID: 18706692
Rapamycin shows anticancer activity in primary chronic lymphocytic leukemia cells in vitro, as single agent and in drug combination.
Leukemia & lymphoma Dec, 2008 | Pubmed ID: 19052982
In vitro activity of 20 agents in different prognostic subgroups of chronic lymphocytic leukemia--rolipram and prednisolone active in cells from patients with poor prognosis.
European journal of haematology Jul, 2009 | Pubmed ID: 19245531
Differential genome-wide array-based methylation profiles in prognostic subsets of chronic lymphocytic leukemia.
Blood Jan, 2010 | Pubmed ID: 19897574
Distinct gene expression profiles in subsets of chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors.
Haematologica Dec, 2010 | Pubmed ID: 20801898
TP53 Mutations are infrequent in newly diagnosed chronic lymphocytic leukemia.
Leukemia research Feb, 2011 | Pubmed ID: 20870288
Quantitative evaluation of p16(INK4a) promoter methylation using pyrosequencing in de novo diffuse large B-cell lymphoma.
Leukemia research Apr, 2011 | Pubmed ID: 21035853
LPL is the strongest prognostic factor in a comparative analysis of RNA-based markers in early chronic lymphocytic leukemia.
Haematologica Aug, 2011 | Pubmed ID: 21508119
Presence of FLT3-ITD and high BAALC expression are independent prognostic markers in childhood acute myeloid leukemia.
Blood Nov, 2011 | Pubmed ID: 21967978
Mantle cell lymphoma displays a homogenous methylation profile: a comparative analysis with chronic lymphocytic leukemia.
American journal of hematology Apr, 2012 | Pubmed ID: 22374828
Screening for cytotoxic compounds in poor-prognostic chronic lymphocytic leukemia.
Anticancer research Aug, 2012 | Pubmed ID: 22843883
Distinct transcriptional control in major immunogenetic subsets of chronic lymphocytic leukemia exhibiting subset-biased global DNA methylation profiles.
Epigenetics Dec, 2012 | Pubmed ID: 23154584
ANGPT2 promoter methylation is strongly associated with gene expression and prognosis in chronic lymphocytic leukemia.
Epigenetics Jul, 2013 | Pubmed ID: 23803577
A key role for EZH2 in epigenetic silencing of HOX genes in mantle cell lymphoma.
Epigenetics Dec, 2013 | Pubmed ID: 24107828
microRNA-34b/c on chromosome 11q23 is aberrantly methylated in chronic lymphocytic leukemia.
Epigenetics Jun, 2014 | Pubmed ID: 24686393
The risk-associated long noncoding RNA NBAT-1 controls neuroblastoma progression by regulating cell proliferation and neuronal differentiation.
Cancer cell Nov, 2014 | Pubmed ID: 25517750
MCPH1 maintains long-term epigenetic silencing of ANGPT2 in chronic lymphocytic leukemia.
The FEBS journal May, 2015 | Pubmed ID: 25703238
Epigenetic silencing of miR-26A1 in chronic lymphocytic leukemia and mantle cell lymphoma: Impact on EZH2 expression.
Epigenetics May, 2016 | Pubmed ID: 27052808
Global DNA methylation profiling reveals new insights into epigenetically deregulated protein coding and long noncoding RNAs in CLL.
Clinical epigenetics , 2016 | Pubmed ID: 27777635
JoVE Hakkında
Telif Hakkı © 2020 MyJove Corporation. Tüm hakları saklıdır